Polyhexamethylene biguanide (PHMB) / chlorhexidine (compounded)
Anti-infective · Rx (compounded)
Rx (compounded)Anti-infectiveAntiamoebicPreservative-free option
| Strength | PHMB 0.02-0.08%; chlorhexidine 0.02% |
|---|---|
| Typical quantity | 5-10 mL bottle, compounded, ~$30-100 |
| Cash cost / month | Moderate · ~$20-100 |
| Drug class | Anti-amoebic biguanide (compounded) |
| Mechanism of action | Cationic biguanides that disrupt the amoebic cell membrane and are cysticidal, active against both trophozoites and the resistant cyst form of Acanthamoeba. |
| Indication / reason for use | Acanthamoeba keratitis, a devastating, often contact-lens-related infection (tap-water rinsing, swimming/showering in lenses, poor case hygiene). |
| Usual adult dosing | 1 drop q1h day and night for 3-7 days, then q1h while awake for weeks; prolonged taper over months, frequently as biguanide + diamidine (e.g. propamidine/hexamidine) dual therapy. |
| Preservative | Preservative-free (compounded) , a preservative-free option exists |
| Contact lenses | Absolute contraindication to lens wear; central to prevention counselling for all lens patients. |
| Common / important adverse effects | Surface toxicity with prolonged use, limbitis, scleritis, keratopathy. |
| Contraindications & cautions | Hypersensitivity. |
| Pregnancy / lactation | Limited data; disease severity usually dictates treatment. |
| Trade names | Compounded PHMB 0.02-0.08%, Chlorhexidine 0.02% |
| Practice notes | Suspect in any contact-lens wearer with disproportionate pain, a ring infiltrate, radial keratoneuritis, or a 'herpes' keratitis not responding to antivirals, refer urgently for confocal microscopy and culture. |
Chair-side reference only. Dosing, contraindications and pregnancy guidance here are not exhaustive. Confirm against the current prescribing information and the patient’s full history before prescribing or advising.